From the Desk of Steve Strazza and Alfonso Depablos
The most significant transaction on today’s list comes in a Form 4 filing by Venrock Healthcare Capital Partners.
The firm reported a purchase of roughly $1.2 million in KalVista Pharmaceuticals Inc $KALV.